-
Antonia M. Joussen
From the Massachussetts Eye and Ear Infirmary, the
Department of Vitreoretinal Surgery, Center for Ophthalmology and Center for Molecular Medicine (ZMMK), University of Cologne, Cologne, Germany; the
-
Vassiliki Poulaki
From the Massachussetts Eye and Ear Infirmary, the
-
Nicholas Mitsiades
Department of Adult Oncology, Dana-Farber Cancer Institute, and the
-
Stephen U. Stechschulte
From the Massachussetts Eye and Ear Infirmary, the
-
Bernd Kirchhof
Department of Vitreoretinal Surgery, Center for Ophthalmology and Center for Molecular Medicine (ZMMK), University of Cologne, Cologne, Germany; the
-
Darlene A. Dartt
Schepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts; the
-
Guo-Hua Fong
Center for Vascular Biology, University of Connecticut Health Center, Farmington, Connecticut; and
-
John Rudge
Regeneron Pharmaceuticals, Inc., Tarrytown, New York.
-
Stanley J. Wiegand
Regeneron Pharmaceuticals, Inc., Tarrytown, New York.
-
George D. Yancopoulos
Regeneron Pharmaceuticals, Inc., Tarrytown, New York.
-
Anthony P. Adamis
From the Massachussetts Eye and Ear Infirmary, the